chronic treatment of rats with adrenalin by means of a subcutaneous depot capsule ( cont . 40 mg dry adrenalin/hcl , merck , ca . 10 mg ascorbic acid and ca . 0.4 ml 0.9 % nacl , and sealed with a dialysis membrane to provide constant adrenalin output ) leads after a primary hyperglycaemic phase to hypoglycaemia .
C0001636
adrenalin/hcl
C0014563
adrenalin